Keywords
SARS-CoV-2, COVID-19, Left Ventricular Thrombus, heart failure
Abstract
Current scientific evidence shows that SARS-CoV-2 infection is associated with an increased risk of thromboembolic events. In patients with ischaemic heart disease and heart failure, thrombi of the left ventricle can increase patient mortality, mainly due to the risk of systemic embolization. Given the hypercoagulable state associated with COVID-19, such events may be more likely. We describe a patient hospitalized for congestive heart failure and SARS-CoV-2 infection who was diagnosed with a thrombus in the left ventricle. After the thrombus was identified on echocardiography and treated with anticoagulation, it completely resolved and cardiac function improved.
References
![](https://www.ejcrim.com/public/journals/1/submission_2559_2175_coverImage_en_US.jpg)
Views: 673
HTML downloads: 173
PDF downloads: 360
Published:
2021-05-14
Issue:
2021: Vol 8 No 5
(view)